Article Information
History
- May 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Iowis Zhu1,2,*,
- Raymond Liu1,2,*,
- Axel Hyrenius-Wittsten1,2,
- Dan I. Piraner1,2,
- Josef Alavi1,2,
- Divya V. Israni3,
- Ahmad S. Khalil3,4 and
- Kole T. Roybal1,2,5,6,7,8,†
- 1Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, 94143, USA
- 2Parker Institute for Cancer Immunotherapy, San Francisco, California, 94143, USA
- 3Department of Biomedical Engineering and Biological Design Center, Boston University, Boston, MA, 02215, USA
- 4Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, 02115, USA
- 5Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, 94158, USA
- 6Chan Zuckerberg Biohub, San Francisco, California, 94158, USA
- 7Gladstone UCSF Institute for Genetic Immunology, San Francisco, CA, 94107, USA
- 8UCSF Cell Design Institute, San Francisco, California, 94158, USA
- ↵†Corresponding author: Email: kole.roybal{at}ucsf.edu
↵* These authors contributed equally to this work.